NEW YORK (GenomeWeb News) – Med Fusion today said that it has inked a validation and market development pact with Theranostics Health aimed at validating the clinical utility of Theranostics Health's personalized medicine assays.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.
A company says it can generate likenesses of people based on their genetic profiles.
IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.
In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.